To analyze the correlations between the MYD88, FAT1, MALT1, ROS1, CREBBP, KMT2D, TET2, and TRAF3 mutations and the clinical parameters of patients with lymphoma, we divided the mutations into positive and negative. Here, MYD88 is linked to lymphoma.